EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Nephro Care India's enterprise value is ₹2,247.0 Mil.
Nephro Care India's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was ₹35.1 Mil. Therefore, Nephro Care India's EV-to-EBITDA for today is 63.94.
The historical rank and industry rank for Nephro Care India's EV-to-EBITDA or its related term are showing as below:
NSE:NEPHROCARE'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 58.43 Med: 92.37 Max: 145.41
Current: 63.94
During the past 3 years, the highest EV-to-EBITDA of Nephro Care India was 145.41. The lowest was 58.43. And the median was 92.37.
NSE:NEPHROCARE's EV-to-EBITDA is ranked worse than 92.56% of 497
companies
in the Healthcare Providers & Services industry
Industry Median: 12.12
vs NSE:NEPHROCARE: 63.94
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Nephro Care India EV-to-EBITDA Historical Data
The historical data trend for Nephro Care India's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Nephro Care India EV-to-EBITDA Chart
Nephro Care India Annual Data
Trend
Mar21
Mar22
Mar23
EV-to-EBITDA
-
-
-
Nephro Care India Semi-Annual Data
Mar21
Mar22
Mar23
Sep24
EV-to-EBITDA
-
-
-
-
Competitive Comparison of Nephro Care India's EV-to-EBITDA
For the Medical Care Facilities subindustry, Nephro Care India's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nephro Care India's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nephro Care India's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Nephro Care India's EV-to-EBITDA falls into.
Nephro Care India's current Enterprise Value is ₹2,247.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nephro Care India's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was ₹35.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nephro Care India (NSE:NEPHROCARE) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Nephro Care India's PE Ratio (TTM) for today is calculated as:
Nephro Care India's share price for today is ₹137.60.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nephro Care India's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹1.550.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Thank you for viewing the detailed overview of Nephro Care India's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Nephro Care India Ltd is a Kolkata-based healthcare provider specializing in comprehensive medical services for renal patients. The company serves as a one-stop treatment center, offering a broad spectrum of clinical and lifestyle solutions, along with specialized treatments for renal insufficiency. Its holistic care framework addresses not only the medical and physiological aspects of treatment but also focuses on lifestyle and spiritual wellness, providing an integrated approach to patient care.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:NEPHROCARE has been successfully added to your